Non-interventional post-authorization study of belzutifan in adult patients with von Hippel-Lindau disease-associated renal cell carcinoma, pancreatic neuroendocrine tumor and/or central nervous system hemangioblastoma (MK-6482-026)

Documents

Study protocol

Updated protocol

MK-6482-026-00-v4_Final-Redaction.pdf

First published: 05/05/2025

Study results

No information provided.

Study report

No information provided.

Other information

Study, other information

D1_PPLS_EUPAS 108114_for pub_12Mar2025_V1-0_MK-6482-026-04.pdf

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.